Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/24 14:52 | 7/15/24 | PHAT | Health | Drug | Pharmaceutical Preparations | Nabulsi Azmi | NJ | O | COO | 1 | S | -128 | 11.72 | 0 | -11 | 1,030 | D | |||||||||||||||
7/17/24 14:51 | 1/19/24 | PHAT | Health | Drug | Pharmaceutical Preparations | Henderson Molly | NJ | O | CFO,CBO | 5 | S.d | -264 | 9.20 | 0 | -29 | 106 | D | |||||||||||||||
7/17/24 14:50 | 7/15/24 | PHAT | Health | Drug | Pharmaceutical Preparations | Curran Terrie | NJ | DO | P,Chief | 2 | S | -550 | 10.85 | 0 | -51 | 415 | D | |||||||||||||||
1/25/24 06:13 | 1/24/24 | PHAT | Health | Drug | Pharmaceutical Preparations | Takeda Pharmaceutical Co Ltd | M0 | T | 1 | S | -30,000 | 8.10 | 0 | -3,704 | 3,756 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |